Portfolio Update

Merrill Lynch Greater Europe IT PLC 23 February 2007 MERRILL LYNCH GREATER EUROPE INVESTMENT TRUST plc All information is at 31 January 2007 and unaudited. Performance at month end with net income reinvested One Three One Since launch Month Months Year (20Sep04) Net asset value 1.6% 6.7% 17.1% 79.5% Share price 1.8% 7.0% 13.8% 72.3% FTSE World Europe ex UK 1.0% 6.1% 17.6% 66.8% Sources: BlackRock and Datastream. At month end Net asset value: 175.23p Includes net revenue of 0.11p Share price: 168.00p Discount to NAV: 4.1% Gearing: 12.9% Net yield: 1.2% Total assets: £246.6m Ordinary shares in issue*: 124,729,045 Benchmark Sector Analysis Total Assets Index Country Analysis Total Assets (%) (%) (%) Financials 42.1 35.2 Germany 18.3 Healthcare 10.9 2.9 France 15.8 Basic Materials 8.8 5.2 Switzerland 14.8 Oil & Gas 8.4 6.9 Italy 10.4 Industrials 8.3 10.4 Spain 6.4 Utilities 5.4 9.2 Russia 6.2 Consumer Goods 4.7 11.5 Ireland 4.0 Telecommunications 4.6 7.6 Netherlands 3.4 Consumer Services 2.6 6.5 Greece 3.0 Other Investments 2.0 - Turkey 2.8 Technology 1.9 4.6 Finland 2.7 Net current assets 0.3 - Belgium 2.1 Denmark 2.0 Sweden 2.0 Norway 1.7 Israel 1.3 UK 1.1 Austria 1.0 Poland 0.7 Net current assets 0.3 ----- ----- ----- 100.0 100.0 100.0 ----- ----- ----- Ten Largest Equity Investments Company Country of Risk Allianz Germany AXA France BBVA Spain Credit Suisse Switzerland Novartis Switzerland Roche Holdings Switzerland Societe Generale France Telefonica Spain UBS Switzerland Unicredito Italy Commenting on the markets, James Macmillan, representing the Investment Manager noted: European equity markets continued on an upward trend in January, with the FTSE World Europe ex UK (net) returning 1.0% in sterling terms. Investors were encouraged by evidence of a 'soft landing' for the US economy and the beneficial impact of falling energy prices on inflation and household purchasing power. The news on economic growth in Europe was also encouraging, particularly in Germany, and the stream of mergers & acquisitions transactions continued into the New Year. The performance in Emerging Europe was negatively impacted by Russia which suffered from a continued decline in the oil price. This was reflected in the MSCI Emerging Europe Index (net) return of -2.9% in sterling terms. The Company's NAV returned 1.6% during January outperforming the reference index by 0.6%. The contribution from the Emerging Europe region was positive due to strong stock selection in Turkey and Russia. The use of flexible gearing was also beneficial with the Company benefiting from being positively geared in a rising market. During the month the Company benefited from strong stock selection across a range of sectors. Within the banking sector the Company's holdings in Kaupthing Bank, Bank of Piraeus, EFG Eurobank Ergas and Sekerbank all had a positive contribution to performance. Elsewhere other strong performing stocks were pharmaceutical group Bayer, steel company Arcelor Mittal, and cement producer Holcim. The stocks which detracted from performance were mainly found in the utility sectors which fell reflecting the downward moves in the power prices. Individual stocks included German and French power utilties RWE, E.On and EDF. Other stocks to have a negative effect were steel pipe manufacturer Vallourec, food manufacturer Nestle and re-insurer Munich Re. During the month the Company increased its exposure to the pharmaceutical and material sectors through the purchase of holdings in Roche, Teva Pharma and Holcim. These transactions were funded by reducing the Company's exposure to utilities and food beverage and tobacco through the sale of E.On and Nestle stock. The Company continues to have a bias towards financials, through banks and diversified financials, along with pharmaceuticals, materials and energy. Exposure to Emerging Europe increased during the month to finish at 11%. The Company ended the month with a net market exposure of 112.9%. We remain positive on the prospects for European equities. The latest evidence appears to suggest that the Global economy remains in robust health with a slight tempering of growth rather than the emergence of a recession or a serious slowdown. European companies have generally reported strong Q4 results, and profits have proved resilient to a modest slowdown in the US, due to robust export demand from Asia and corporate restructuring. European equity valuations are attractive, earnings growth is strong and earnings revisions remain positive. Latest Latest information is available by typing www.blackrock.co.uk/its on the internet, 'BLRKINDEX' on Reuters, 'BLRK' on Bloomberg or '8800' on Topic 3 (ICV terminal). 23 February 2007 This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings